Enanta Pharmaceuticals | Omsætningsaktiver

Current Assets Lave om Dato
AbbVie USD 33.22B 4.37B 2023-09
Amgen USD 30.33B 18.14B 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Insmed USD 929.06M 2.49M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Ligand Pharmaceuticals USD 237.43M 16.56M 2023-12
Merck USD 31.95B 1.98B 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pfizer USD 74.01B 665M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Enanta Pharmaceuticals Omsætningsaktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.